Lab Automation Market is projected to expand at a CAGR of 6.00% to reach 14.09 Billion by 2032

𝐆𝐥𝐨𝐛𝐚𝐥 𝐥𝐚𝐛 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐚𝐧𝐝 𝐬𝐡𝐚𝐫𝐞 𝐢𝐬 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟓.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐚𝐧 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 𝟏𝟒.𝟎𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐚𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐬𝐭𝐮𝐝𝐲 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡. 𝐁𝐞𝐬𝐢𝐝𝐞𝐬, 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐭𝐞𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐬 𝐚 𝐫𝐨𝐛𝐮𝐬𝐭 𝟔.𝟎𝟎% 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐢𝐦𝐞𝐟𝐫𝐚𝐦𝐞, 𝟐𝟎𝟐𝟒 - 𝟐𝟎𝟑𝟐

Increased acquisition of mechanized instruments is observed in educational and research organizations targeting to improve efficiency and decrease the time assigned to labor exhaustive chores. Besides, the proliferating usage of mechanized instruments in drug detection and advancement is arranged to push the market growth in the expected future.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/lab-automation-market/request-for-sample

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

The main players in the lab automation market are accepting several deliberated capabilities to sustain their market presence. Further, these techniques assist players in reinforcing their business directions. Market leaders are enumerated as follows:
• Abbott
• Agilent Technologies
• Bio-Rad Laboratories
• CrelioHealth
• Danaher
• Dassault Systèmes
• Hoffmann-La Roche
• Illumia
• INTEGRA Biosciences
• LabLynx
• LabVantage
• Peak Analysis & Automation
• Siemens Healthineers
• Tecan
• Thermo Fisher Scientific

Laboratory automation is the consolidation of mechanized technologies into the laboratory to sanction contemporary and enhanced procedures. Normally, lab automation solutions discard the majority of tedious chores in a lab, such as library devising or liquid management, that have usually been presented manually by lab consultants and scientists. But as this technology progresses additional intricate procedures and even entire productivity can be automated.

𝐆𝐞𝐭 𝐀𝐡𝐞𝐚𝐝 𝐰𝐢𝐭𝐡 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/buy/2938/2

Growingly automated technology is a need in present day's labs to stay aggressive and encounter demand. Present-day labs encounter growing pressures to enhance production, productivity, and standards while their resources and workforce are frequently prolonged to the zenith. The requirement to handle intricate tests, countless productivity, and protracted specimen preparation showcase notable provocations to labs of all configurations, proportions, and fortes.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

• North America emerged as an aggressive player in the market. This can be attributed to several hospitals' entry into lab automation to confront staff dearth, improve the accuracy of test outcomes, and uplift patient care. Traditional device-dependent diagnostics were expensive for insurance providers, pushing some to decrease recompense over the past decade.

• The European lab automation industry exhibits robust growth and innovation due to the repeatedly escalating acquisition of speedy testing and point-of-care solutions in European hospitals. Emergency departments are enfolding speedy flu tests to accelerate diagnosis and relieve the strain during flu season.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐚𝐧𝐝 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐯𝐢𝐭𝐲: The need for increased efficiency, productivity, and reproducibility in laboratory workflows, particularly in drug discovery, genomics, proteomics, and clinical diagnostics, drives the adoption of lab automation solutions.

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲: Continuous advancements in robotics, artificial intelligence, machine learning, and sensor technologies enable the development of more sophisticated and integrated lab automation systems with higher throughput, accuracy, and flexibility.

𝐑𝐢𝐬𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐥𝐞𝐱𝐢𝐭𝐲 𝐨𝐟 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: The growing complexity of biological research, including the need for large-scale screening, multi-omics analysis, and personalized medicine approaches, fuels the demand for automated laboratory solutions capable of handling complex experimental workflows.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
https://www.polarismarketresearch.com/industry-analysis/lab-automation-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭
• Software
• System

𝐁𝐲 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧
• Task Targeted Automation
• Total Laboratory Automation
• Subtotal Automation

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
• Genomics Solutions
• Microbiology
• Drug Discovery
• Clinical Diagnostics
• Others

𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫
• Hospitals and Diagnostic Laboratories
• Forensic Laboratories
• Environmental Testing Laboratories
• Food and Beverages
• Research and Academic Institutes
• Biotechnology and Pharma Companies

𝐋𝐚𝐛 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• In 2022, the System segment secured the most significant share of revenue. The Systems segment is a key player in the market, with an anticipated robust CAGR throughout the forecast period. Lab automation systems cover various phases of the product life cycle. Remarkably, microplate readers are currently in their initial adoption phase, suggesting that their market development is still in its infancy. The incorporation of automated robots in liquid handling segments is aimed at providing support to human operators.

• The Drug Discovery segment represented the largest market share throughout the forecast period. This segment maintains its dominance in the market throughout the forecast period. Drug discovery laboratories have the ability to significantly streamline the process of designing, synthesizing, and screening compounds, condensing what would typically take weeks to just days, despite the inherent complexity and time-intensive nature of the process. This complexity is a major factor contributing to the limited participation of individuals in the drug discovery process.

• The Subtotal Automation segment held the leading market share throughout the forecast period. This segment, which primarily focuses on partial automation, claims the largest share of the market during the forecast period. Laboratory processes are commonly categorized into preanalytical, analytical, and post-analytical stages. When one or two of these stages undergo automation, it falls within the domain of partial automation. These are typically autonomous specimen processing systems designed to execute various tasks. Partial automation presents a cost-effective alternative compared to comprehensive laboratory automation setups.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐂𝐥𝐞𝐚𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/medical-device-cleaning-market

𝐂𝐚𝐩𝐧𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/capnography-device-market

𝐂𝐨𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐀𝐧𝐝 𝐀𝐥𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐯𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/complementary-alternative-medicine-market

𝐃𝐨𝐰𝐧𝐬𝐭𝐫𝐞𝐚𝐦 𝐏𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/downstream-processing-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.